News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,238 Results
Type
Article (45771)
Company Profile (330)
Press Release (715120)
Multimedia
Podcasts (128)
Webinars (22)
Section
Business (212593)
Career Advice (2122)
Deals (36585)
Drug Delivery (138)
Drug Development (82811)
Employer Resources (177)
FDA (17083)
Job Trends (15450)
News (357910)
Policy (33638)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2753)
Accelerated approval (51)
Adcomms (27)
Allergies (177)
Alliances (52625)
ALS (216)
Alzheimer's disease (1834)
Antibody-drug conjugate (ADC) (487)
Approvals (17481)
Artificial intelligence (733)
Autoimmune disease (314)
Automation (58)
Bankruptcy (367)
Best Places to Work (11929)
BIOSECURE Act (20)
Biosimilars (225)
Biotechnology (216)
Bladder cancer (201)
Brain cancer (74)
Breast cancer (780)
Cancer (6032)
Cardiovascular disease (490)
Career advice (1807)
Career pathing (44)
CAR-T (349)
CDC (59)
Celiac Disease (3)
Cell therapy (948)
Cervical cancer (49)
Clinical research (71828)
Collaboration (2180)
Company closure (6)
Compensation (1428)
Complete response letters (81)
COVID-19 (2834)
CRISPR (116)
C-suite (1189)
Cystic fibrosis (160)
Data (8179)
Decentralized trials (3)
Denatured (46)
Depression (165)
Dermatology (92)
Diabetes (602)
Diagnostics (7244)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (347)
Drug pricing (204)
Drug shortages (33)
Duchenne muscular dystrophy (295)
Earnings (93886)
Editorial (67)
Employer branding (22)
Employer resources (157)
Events (124798)
Executive appointments (1125)
FDA (20934)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (35)
Funding (1807)
Gene editing (252)
Generative AI (63)
Gene therapy (765)
GLP-1 (1080)
Government (4845)
Grass and pollen (7)
Guidances (413)
Healthcare (19783)
HIV (85)
Huntington's disease (56)
IgA nephropathy (100)
Immunology and inflammation (296)
Immuno-oncology (96)
Indications (197)
Infectious disease (3191)
Inflammatory bowel disease (223)
Inflation Reduction Act (14)
Influenza (141)
Intellectual property (304)
Interviews (331)
IPO (17016)
IRA (51)
Job creations (3836)
Job search strategy (1503)
JPM (62)
Kidney cancer (19)
Labor market (103)
Layoffs (581)
Leadership (42)
Legal (8177)
Liver cancer (103)
Longevity (33)
Lung cancer (788)
Lymphoma (437)
Machine learning (63)
Management (63)
Manufacturing (1095)
MASH (199)
Medical device (14701)
Medtech (14837)
Mergers & acquisitions (20844)
Metabolic disorders (1545)
mRNA (237)
Multiple sclerosis (191)
NASH (17)
Neurodegenerative disease (438)
Neuropsychiatric disorders (105)
Neuroscience (3395)
Neurotech (1)
NextGen: Class of 2026 (6855)
Non-profit (4669)
Now hiring (78)
Obesity (714)
Opinion (303)
Ovarian cancer (232)
Pain (260)
Pancreatic cancer (315)
Parkinson's disease (378)
Partnered (34)
Patents (619)
Patient recruitment (700)
Peanut (65)
People (61956)
Pharmaceutical (66)
Pharmacy benefit managers (32)
Phase 1 (22555)
Phase 2 (31620)
Phase 3 (23421)
Pipeline (9112)
Policy (331)
Postmarket research (2588)
Preclinical (9697)
Press Release (71)
Prostate cancer (316)
Psychedelics (54)
Radiopharmaceuticals (354)
Rare diseases (1109)
Real estate (6303)
Recruiting (70)
Regulatory (26135)
Reports (57)
Research institute (2557)
Resumes & cover letters (365)
Rett syndrome (39)
RNA editing (25)
RSV (89)
Schizophrenia (181)
Series A (305)
Series B (219)
Service/supplier (14)
Sickle cell disease (114)
Special edition (24)
Spinal muscular atrophy (167)
Sponsored (49)
Startups (3910)
State (2)
Stomach cancer (18)
Supply chain (130)
Tariffs (87)
The Weekly (79)
Vaccines (1156)
Venture capital (117)
Weight loss (462)
Women's health (131)
Worklife (20)
Date
Today (189)
Last 7 days (597)
Last 30 days (3545)
Last 365 days (31004)
2026 (13745)
2025 (30957)
2024 (36206)
2023 (41132)
2022 (52398)
2021 (56990)
2020 (55609)
2019 (48404)
2018 (36438)
2017 (33538)
2016 (33138)
2015 (39357)
2014 (32941)
2013 (27985)
2012 (30243)
2011 (30847)
2010 (28809)
Location
Africa (782)
Alabama (96)
Alaska (7)
Arizona (364)
Arkansas (16)
Asia (42472)
Australia (7076)
California (13714)
Canada (3844)
China (1412)
Colorado (585)
Connecticut (598)
Delaware (426)
Europe (93603)
Florida (2029)
Georgia (448)
Hawaii (3)
Idaho (65)
Illinois (1099)
India (92)
Indiana (619)
Iowa (24)
Japan (560)
Kansas (135)
Kentucky (53)
Louisiana (46)
Maine (76)
Maryland (1632)
Massachusetts (9891)
Michigan (400)
Minnesota (748)
Mississippi (7)
Missouri (157)
Montana (36)
Nebraska (29)
Nevada (148)
New Hampshire (91)
New Jersey (3592)
New Mexico (31)
New York (3567)
North Carolina (1760)
North Dakota (11)
Northern California (6863)
Ohio (415)
Oklahoma (25)
Oregon (45)
Pennsylvania (2735)
Puerto Rico (30)
Rhode Island (51)
South America (1170)
South Carolina (87)
South Dakota (2)
Southern California (5419)
Tennessee (219)
Texas (2194)
United States (48528)
Utah (412)
Vermont (1)
Virginia (332)
Washington D.C. (81)
Washington State (1107)
West Virginia (4)
Wisconsin (143)
Wyoming (2)
761,238 Results for "jenavalve technology inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
JenaValve Appoints Edward Sarnowski as Chief Technology Officer
May 27, 2026
·
4 min read
Press Releases
JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs
May 20, 2026
·
4 min read
Press Releases
JenaValve Appoints Dave Haan as Vice President of Clinical Affairs
May 12, 2026
·
4 min read
Press Releases
JenaValve Appoints John Molyneux to Vice President of Operations
January 29, 2026
·
2 min read
Press Releases
JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
November 11, 2025
·
4 min read
Press Releases
JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States - the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)
April 2, 2026
·
4 min read
Press Releases
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System — the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR) in the United States
March 18, 2026
·
4 min read
Press Releases
JenaValve Announces 1,000th Case with the Trilogy™ Transcatheter Heart Valve (THV) System
November 18, 2025
·
2 min read
Press Releases
JenaValve Announces New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
November 24, 2025
·
4 min read
Biotech Beach
JenaValve’s Trilogy THV System Highlighted at CRT 2024
JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve System, announced highlights from the Cardiovascular Research Technologies Conference 2024.
March 19, 2024
·
2 min read
1 of 76,124
Next
